EGFP-encoding Oncolytic Herpes Simplex Virus 1 (ΔICP27), hTERT-EGFP(Cat#: RepOV-0032XY)
DatasheetThis product is a EGFP encoding oncolytic herpes simplex virus, which is based on HSV-1 with ICP27 deleted. ICP27 is highly cytotoxic probably due to its secondary role of preventing the splicing of pre-mRNAs in favour of translation from the mainly unspliced hepes RNAs. Deletion of ICP27 might produce a safer and less cytotoxic system when combined with other oncolytic-rendered modifications. This product can be used in oncolytic virotherapy research and further recombinant HSV construction.
Specifications | |
|---|---|
| Family | Herpesviridae |
| Species | Herpes simplex virus |
| Serotype | Herpes simplex virus 1 |
| Backbone | HSV-1 (ΔICP27) |
| Backbone Background | Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as human herpesvirus 1 and 2 (HHV-1 and HHV-2), are two members of the human Herpesviridae family, a set of viruses that produce viral infections in the majority of humans. Modified Herpes simplex virus is considered as a potential therapy for cancer and has been extensively clinically tested to assess its oncolytic ability. |
| Gene Modification | ΔICP27 |
| Promoter | hTERT |
| Transgene | EGFP |
| Type of Transgene | Reporter gene |
| Related Target/Protein | Enhanced green fluorescent protein |
| Capsid Modification | None |
| Titer | >1*10^8 PFU |
| Related Diseases | Tumor |
Transgene | |
|---|---|
| Alternative Names | EGFP, egfp, enhanced green fluorescent protein |
| Gene ID | 20473140 |
Information | |
|---|---|
| Introduction | EGFP, derived from Aequorea victoria, is a unique GFP variant which contains chromophore mutations that make the protein 35 times brighter than wild-type GFP, and is codon-optimized for higher expression in mammalian cells. These changes in the GFP coding sequence provide an enhanced GFP (EGFP) that greatly increases the sensitivity of the reporter protein. |
Customer Reviews and Q&As |
|---|
|
There are currently no customer reviews or questions for EGFP-encoding Oncolytic Herpes Simplex Virus 1 (ΔICP27), hTERT-EGFP (RepOV-0032XY). Click the button below to contact us or submit your feedback about this product. |
All products and services are for Research Use Only. Not For Clinical Use.
Other products
- hTNFα-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP27), hTERT-hTNFα (CAT#: CyOV-0075XY)
- GM-CSF-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP6, ΔΔICP34.5), CMV-GM-CSF (CAT#: CyOV-0031XY)
- GM-CSF-expressing Oncolytic Herpes Simplex Virus 2 (ΔRL), IE4/5-GM-CSF (CAT#: CyOV-0353XY)
- HSP70-expressing Oncolytic Herpes Simplex Virus 2 (ΔRL), IE4/5-HSP70 (CAT#: CyOV-0354XY)
- MMP9-expressing Oncolytic Herpes Simplex Virus 1 (ΔΔICP0), SV40-MMP9 (CAT#: CyOV-0259XY)
- CCL17-expressing Oncolytic Herpes Simplex Virus 1 (ΔΔICP0), hTERT-CCL17 (CAT#: CyOV-0113XY)
- IL-10-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP6, ΔΔICP34.5), IE4/5-IL-10 (CAT#: CyOV-0177XY)
- ING4-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP27), CMV-ING4 (CAT#: CyOV-0006XY)
PRODUCTS
Online Inquiry